Pharmacokinetic (PK) interactions between capecitabine (X), oxaliplatin (O) and bevacizumab (A) when used in combination for first-line treatment of metastatic colorectal cancer (MCRC)Barbara J. Brennan, S Choudhury, Lillian L. Siu et al.|Journal of Clinical Oncology|2007Cited by 5
Antenatal Atazanavir: A Retrospective Analysis of Pregnancies Exposed to AtazanavirMiriam Samuel, Annemiek de Ruiter, Rageshri Dhairyawan et al.|Infectious Diseases in Obstetrics and Gynecology|2014Cited by 4